一周医药速览(1.5-1.9)

财经网
Jan 09

英硅智能:与施维雅达成价值 8.88 亿美元的抗肿瘤药物研发合作1月5日,英硅智能(Insilico Medicine)宣布与施维雅(Servier)达成了一项总金额达 8.88 亿美元的研发合作。该合作将英硅智能人工智能驱动的药物研发平台与施维雅在抗肿瘤药物研发领域的全球专业优势相结合,聚焦于创新抗肿瘤疗法的发现与开发。根据协议,英硅智能将有资格获得最高 3200 万美元的首付款及近期研发里程碑...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10